NantKwest, Inc. (NK)
(Delayed Data from NSDQ)
$1.15 USD
0.00 (0.00%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.16 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$1.15 USD
0.00 (0.00%)
Updated May 3, 2019 04:00 PM ET
After-Market: $1.16 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Should First Trust Small Cap Growth AlphaDEX ETF (FYC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for FYC
New Strong Sell Stocks for December 30th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
5 Medical Outperformers That Might Lose Steam in 2021
by Zacks Equity Research
Here we discuss some biotech stocks, which are up this year so far but might not be good additions to your portfolio.
Analysts Estimate NantKwest (NK) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
NantKwest (NK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Options Traders Expect Huge Moves in NantKwest (NK) Stock
by Zacks Equity Research
Investors need to pay close attention to NantKwest (NK) stock based on the movements in the options market lately.
Will NantKwest Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in NantKwest.
Is the Options Market Predicting a Spike in NantKwest (NK) Stock?
by Zacks Equity Research
Investors need to pay close attention to NantKwest (NK) stock based on the movements in the options market lately.
Analysts Estimate NantKwest (NK) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
NantKwest (NK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
NantKwest Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
NantKwest has been struggling lately, but the selling pressure may be coming to an end soon.
A Deep Dive into the Business of the NBA
by Benjamin Rains
On this episode of the Full-Court Finance podcast, Associate Stock Strategist Ben Rains breaks down the booming, international business of the NBA.
3 Stocks Under $10 That Surged Today
by Benjamin Rains
Here at Zacks, we encourage investors to follow our proven stock-picking system, which places a great deal of emphasis on the importance of earnings estimate revisions in order to identify winning stocks. However, we also always look to cover stocks, from S&P 500 powers to small cap-firms, when they make newsworthy moves.
Zacks.com featured highlights: Johnson & Johnson, NantKwest, Delek US Holdings, Abbot Labs and Winnebago
by Zacks Equity Research
Zacks.com featured highlights: Johnson & Johnson, NantKwest, Delek US Holdings, Abbot Labs and Winnebago
How to Uncover Institutional Buying
by Kevin Matras
Kevin Matras goes over how to screen for weekly volume increases to uncover institutional buying. Highlighted stocks include JNJ, NK, DK, ABT and WGO.
NantKwest (NK) Looks Good: Stock Moves Up 8.5% in Session
by Zacks Equity Research
NantKwest, Inc. (NK) moved big last session, as its shares rose over 8% on the day.
Stocks Most Likely to Beat Earnings for the Week of December 12th
by Zacks Equity Research
Here are four stocks that are likely to beat earnings for the week of December 12th: